Check-Cap Ltd. (CHEK)
NASDAQ: CHEK · IEX Real-Time Price · USD
2.285
-0.015 (-0.65%)
At close: Apr 26, 2024, 4:00 PM
2.370
+0.085 (3.72%)
After-hours: Apr 26, 2024, 4:30 PM EDT

Company Description

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel.

Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.

Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

Check-Cap Ltd.
Check-Cap logo
Country Israel
Founded 2004
IPO Date Feb 19, 2015
Industry Diagnostics & Research
Sector Healthcare
Employees 85
CEO Alex Ovadia

Contact Details

Address:
Abba Hushi Avenue, P.o. Box 1271
Isfiya, L3 3009000
Israel
Phone 972-4-8303400
Website check-cap.com

Stock Details

Ticker Symbol CHEK
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001610590
CUSIP Number M2361E203
ISIN Number IL0011336851
SIC Code 3844

Key Executives

Name Position
Alex Ovadia Chief Executive Officer and Director
Dr. Yoav Kimchy Ph.D. Founder and Interim Chief Technology Officer
Joshua Belkar Vice President of Operations
Iris Even-Tov Interim Chief Financial Officer
Noa Reshef M.B.A. Director of Human Resources

Latest SEC Filings

Date Type Title
Apr 15, 2024 6-K Report of foreign issuer
Apr 10, 2024 6-K/A Filing
Apr 8, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Apr 8, 2024 6-K Report of foreign issuer
Apr 5, 2024 6-K Report of foreign issuer
Apr 1, 2024 SC 13D General statement of acquisition of beneficial ownership
Mar 28, 2024 6-K Report of foreign issuer
Mar 28, 2024 6-K Report of foreign issuer
Mar 22, 2024 6-K Report of foreign issuer
Mar 20, 2024 6-K Report of foreign issuer